Pharmacovigilance Outsourcing Market –By Type (Adverse drug reaction capture, Case Processing, Reporting and Submission, Report Publishing, Quality check, Risk management, Knowledge management, Enabling architecture) By End User (Pharmaceutical Industry, Research organization, Hospitals) By Service Providers (Business Processing Outsourcing, Contract Research Organizations) By Region (North America, Europe, Asia Pacific, Middle East & Africa, RoW) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: Aug 2020
No. of Pages: 180
Status: Published
Report Code: ARI100862
Summary
Pharmacovigilance outsourcing is transfer of drug safety processes and functions to a third-party provider. These services are outsourced by small and mid-size pharmaceutical & biotechnology companies so as to save lots of costs and specialize in company’s core activities. A number of the common PV activities that are outsourced include development of risk management plans, risk evaluation mitigation strategy also creating & submitting aggregate, collecting ADR information, case processing activities and expedited PV reports. The demand for robust compliance systems and experienced talent has raised the value of maintaining the infrastructure necessary to support pharmacovigilance; hence, it is necessary for industries to outsource such services.
Growing importance of new drug development for chronic diseases treatments, quality assurance, statistical analysis and clinical trials, remote monitoring for clinical operations, quality assurance, regulatory affairs, increasing preference of pharma companies towards PV outsourcing facilities and rising number of unfavorable events and other safety concerns associated with the medical products are a number of the elemental factors that are driving the worldwide pharmacovigilance outsourcing market growth globally. Large numbers of pharma companies are primarily that specializes in the outsourcing PV services so as to attenuate the operational expenses and reduce the overall cost, thereby fueling the expansion of the market. Nevertheless, risks associated with security of data like mistreatment of patient’s data may hinder the growth of the worldwide pharmacovigilance outsourcing market.
Maintaining compliance amidst increasing regulatory complexity, especially during a global context, needs individuals skilled in risk management & knowledgeable of regulatory and compliance operations; these professionals are currently in short supply and high demand. Organizations are struggling to extend operational budgets to supply training and to realize access to an extended talent pool and risks related to security of data such as mistreatment of patient’s data hampering the market growth.
The prominent players in the global Pharmacovigilance Outsourcing Market are Accenture, BioClinica, Cognizant, Covance, ICON, iGATE Corporation, Genpact, Infosys, TCS, Oracle, PAREXEL and Syneos Health. These players primarily focus on various inorganic strategies including partnerships, acquisitions and mergers to create a global footprint and sustain market competition.
Analyst Commentary
The trend for the outsourcing of pharmacovigilance activities to drug safety specialists is gaining momentum as companies both large and small are looking for ways to reduce costs in some areas in order to maximize the resources available for R & D. Pharmacovigilance activities are process-driven making them ideal candidates for outsourcing. Pharmacovigilance deployments have shown that substantial cost savings of 30-40% can be made by outsourcing pharmacovigilance. It is estimated that more than 80% of pharmaceutical companies outsource at least one pharmacovigilance activity.
Regional Analysis
Asia Pacific industry is poised to exceed USD 3.5 billion revenue by 2026. Increasing volume of clinical trials being conducted in the Asian countries will serve to be a major impact rendering factor in the regional market growth. Developing countries such as China and India are the most favored destinations for PV outsourcing owing to availability of high skill set at lower costs. Moreover, availability of large pool of talented medical, paramedical and non-medical professionals involved in the PV process coupled with presence of refined PV systems in the region will further accelerate the market progression.
Segmentation
Global Pharmacovigilance Outsourcing Market has been segmented on the basis of Type, End User, Service Providers and Region. Based on type Pharmacovigilance Outsourcing market is segmented into Adverse drug reaction capture, Case Processing, Reporting and Submission, Report Publishing, Quality check, Risk management, Knowledge management and Enabling architecture. Based on End User market is segmented into Pharmaceutical Industry, Research organization and Hospitals. Based on Service Providers market is segmented into Business Processing Outsourcing and Contract Research Organizations. Based on Region market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and RoW.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. DataComponent
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Pharmacovigilance Outsourcing Market
Chapter 5. Global Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
5.1. Global Pharmacovigilance Outsourcing Market Share, By Type, 2015 - 2027(USD Million)
5.1.1. Adverse drug reaction capture
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Case Processing
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Reporting and submission
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Report publishing
5.1.4.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.5. Quality check
5.1.5.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.6. Risk management
5.1.6.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.7. Knowledge management
5.1.7.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.7.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.8. Enabling architecture
5.1.8.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.8.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
6.1. Global Pharmacovigilance Outsourcing Market Share, By Service Provider, 2015 - 2027 (USD Million)
6.1.1. Business Processing Outsourcing
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Contract Research Organizations
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Pharmacovigilance Outsourcing Market Overview, By End User, 2015 - 2027(USD Million)
7.1. Global Pharmacovigilance Outsourcing Market Share, By End User, 2015 - 2027 (USD Million)
7.1.1. Pharmaceutical Industry
7.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Research organization
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. Hospitals
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Pharmacovigilance Outsourcing Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Pharmacovigilance Outsourcing Market Share, By Geography, 2015 - 2027(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2027(USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
9.1.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.2. North America Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. North America Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
9.1.4. North America Pharmacovigilance Outsourcing Market Overview, By End User, 2015 - 2027 (USD Million)
9.1.5. North America Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
9.1.5.1. U.S. Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.5.1.2. U.S. Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.5.2.2. Canada Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
9.1.5.3.2. Mexico Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
10.1.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.2. Europe Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Europe Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
10.1.4. Europe Pharmacovigilance Outsourcing Market Overview, By End User,2015 - 2027 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027(USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.1.2. Germany Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.1.3. Germany Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.2.2. France Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.2.3. France Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.3.2. UK Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.3.3. UK Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.4.2. Italy Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.4.3. Italy Pharmacovigilance Outsourcing Market Overview, By Service Provider2015 - 2027(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.5.5.2. Spain Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.5.3. Spain Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.6.3. Rest of Europe Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Asia Pacific Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
11.1.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.2. Asia Pacific Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Pharmacovigilance Outsourcing Market Overview, By End User,2015 - 2027 (USD Million)
11.1.5. Asia Pacific Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.1.2. India Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.1.3. India Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.2.3. China Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.3.2. Japan Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.5.2. Rest of Asia Pacific Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
12.1. Middle East & Africa Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
12.1.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.2. Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By End User,2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.5.1.2. GCC Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
12.1.5.1.3. GCC Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.5.2.2. South Africa Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
12.1.5.2.3. South Africa Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2027(USD Million)
12.1.5.3.2. Rest of Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
12.1.5.3.3. Rest of Middle East & Africa Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Pharmacovigilance Outsourcing Market Overview, By Countries, 2015 - 2027(USD Million)
13.1. South America Pharmacovigilance Outsourcing Market Overview, 2015 - 2027(USD Million)
13.1.1. Market Size and projections, 2015 - 2027(USD Million)
13.1.2. South America Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.3. South America Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027 (USD Million)
13.1.4. South America Pharmacovigilance Outsourcing Market Overview, By End User,2015 - 2027 (USD Million)
13.1.5. South America Pharmacovigilance Outsourcing Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2027(USD Million)
13.1.6.2. Brazil Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
13.1.6.3. Brazil Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2027(USD Million)
13.1.7.2. Argentina Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
13.1.7.3. Argentina Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2027
13.1.8.2. Rest of South America Pharmacovigilance Outsourcing Market Overview, By Type, 2015 - 2027(USD Million)
13.1.8.3. Rest of South America Pharmacovigilance Outsourcing Market Overview, By Service Provider, 2015 - 2027(USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Research organization
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. Accenture
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. BioClinica
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Cognizant
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Covance
15.5. ICON
15.6. iGATE Corporation
15.7. Genpact
15.8. Infosys
15.9. Others
Chapter 16. Pharmacovigilance Outsourcing Market Cost Analysis
16.1. Pharmacovigilance Outsourcing Key Raw Material Analysis
16.1.1. Key Raw Materials
16.1.2. Price Trend of Key Raw Materials
16.1.3. Key Suppliers of Raw Materials
16.1.4. Market Concentration Rate of Raw Materials
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Pharmacovigilance Outsourcing Industrial Chain Analysis
17.2. Upstream Size Sourcing
17.3. Pharmacovigilance Outsourcing Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Pharmacovigilance Outsourcing Market share, By Type, 2020 & 2027 (%)
10. Global Pharmacovigilance Outsourcing Market share, by Adverse drug reaction capture, By Type, 2015 - 2027(USD Million)
11. Global Pharmacovigilance Outsourcing Market share, by Case Processing, By Type, 2015 - 2027 (USD Million)
12. Global Pharmacovigilance Outsourcing Market share, by Reporting and submission, By Type, 2015 - 2027 (USD Million)
13. Global Pharmacovigilance Outsourcing Market share, by Report publishing, By Type, 2015 - 2027 (USD Million)
14. Global Pharmacovigilance Outsourcing Market share, by Quality check, By Type, 2015 - 2027 (USD Million)
15. Global Pharmacovigilance Outsourcing Market share, by Risk management, By Type, 2015 - 2027 (USD Million)
16. Global Pharmacovigilance Outsourcing Market share, by Knowledge management, By Type, 2015 - 2027 (USD Million)
17. Global Pharmacovigilance Outsourcing Market share, by Enabling architecture, By Type, 2015 - 2027 (USD Million)
18. Global Pharmacovigilance Outsourcing Market share, By Service Provider, 2020 & 2027 (%)
19. Global Pharmacovigilance Outsourcing Market share, by Business Processing Outsourcing, By Service Provider, 2015 - 2027(USD Million)
20. Global Pharmacovigilance Outsourcing Market share, by Contract Research Organizations, By Service Provider, 2015 - 2027(USD Million)
21. Global Pharmacovigilance Outsourcing Market share, By End User, 2020 & 2027 (%)
22. Global Pharmacovigilance Outsourcing Market share, by Pharmaceutical Industry, By End User, 2015 - 2027(USD Million)
23. Global Pharmacovigilance Outsourcing Market share, by Research organization, By End User, 2015 - 2027 (USD Million)
24. Global Pharmacovigilance Outsourcing Market share, by Hospitals, By End User, 2015 - 2027 (USD Million)
25. Global Pharmacovigilance Outsourcing Market share, by region, 2020 & 2027 (%)
26. Global Pharmacovigilance Outsourcing Market share, by region, 2015 - 2027(USD Million)
27. North America Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
28. North America Pharmacovigilance Outsourcing Market share, by Countries, 2020 & 2027 (%)
29. U.S. Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
30. Canada Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
31. Mexico Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
32. Europe Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
33. Europe Pharmacovigilance Outsourcing Market share, by Countries, 2020 & 2027 (%)
34. Spain Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
35. UK Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
36. Italy Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
37. Germany Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
38. France Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
39. Rest of Europe Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
40. Asia-Pacific Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
41. Asia-Pacific Pharmacovigilance Outsourcing Market share, by Countries, 2020 & 2027 (%)
42. China Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
43. India Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
44. Australia Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
45. Japan Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
46. Rest of Asia-Pacific Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
47. Middle East & Africa Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
48. Middle East & Africa Pharmacovigilance Outsourcing Market share, by Countries, 2020 & 2027 (%)
49. GCC Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
50. South Africa Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
51. Rest Of Middle East & Africa Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
52. South America Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
53. Brazil Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
54. Mexico Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
55. Argentina Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
56. Rest Of South America Pharmacovigilance Outsourcing Market , 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Pharmacovigilance Outsourcing Market , 2015-2027(USD Million)
4. Lactase requirement, by country, 2015-2027, (USD Million)
5. North America Pharmacovigilance Outsourcing Market , By Type, 2015-2027(USD Million)
6. North America Pharmacovigilance Outsourcing Market , By Service Provider, 2015-2027(USD Million)
7. North America Pharmacovigilance Outsourcing Market , By End User, 2015-2027(USD Million)
8. Europe Pharmacovigilance Outsourcing Market , By Type, 2015-2027(USD Million)
9. Europe Pharmacovigilance Outsourcing Market , By Service Provider, 2015-2027(USD Million)
10. Europe Pharmacovigilance Outsourcing Market , By End User, 2015-2027(USD Million)
11. Asia Pacific Pharmacovigilance Outsourcing Market , By Type, 2015-2027(USD Million)
12. Asia Pacific Pharmacovigilance Outsourcing Market , By Service Provider, 2015-2027(USD Million)
13. Asia Pacific Pharmacovigilance Outsourcing Market , By End User, 2015-2027(USD Million)
14. Middle East & Africa Pharmacovigilance Outsourcing Market , By Type, 2015-2027(USD Million)
15. Middle East & Africa Pharmacovigilance Outsourcing Market , By Service Provider, 2015-2027(USD Million)
16. Middle East & Africa Pharmacovigilance Outsourcing Market , By End User, 2015-2027(USD Million)
17. South America Pharmacovigilance Outsourcing Market , By Type, 2015-2027(USD Million)
18. South America Pharmacovigilance Outsourcing Market , By Service Provider, 2015-2027(USD Million)
19. South America Pharmacovigilance Outsourcing Market , By End User, 2015-2027(USD Million)
20. Global Pharmacovigilance Outsourcing Market, Company Market Share, 2020 - 2027 (%)
21. Accenture: Product Benchmarking
22. Accenture: Financial Performance
23. BioClinica: Product Benchmarking
24. BioClinica: Financial Performance
25. Cognizant: Product Benchmarking
26. Cognizant: Financial Performance
27. Covance : Product Benchmarking
28. Covance : Financial Performance
29. ICON: Product Benchmarking
30. ICON: Financial Performance
31. iGATE Corporation: Product Benchmarking
32. iGATE Corporation: Financial Performance
33. Genpact: Product Benchmarking
34. Genpact: Financial Performance
35. Infosys.: Product Benchmarking
36. Infosys.: Financial Performance
The Leading Key Players in Pharmacovigilance Outsourcing Market
